← FDA Drug Approvals (Drugs@FDA)

ACETAMINOPHEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2025-04-02

Drug application

FDA Application #

ANDA219215

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETAMINOPHEN

Generic name

ACETAMINOPHEN

Active ingredients

ACETAMINOPHEN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Sagent Pharmaceuticals

First approval

2025-04-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown